New user? / Forgot your password?
0 Item | 0,00 €
Item number | 675336 |
CAS | 79-06-1 |
Formula | C3H5NO |
Molecular weight | 71,08 g/mol |
Quantity | 1X250MG |
storage conditions | 20 °C |
CoA / MSDS | Retrieve CoA Retrieve MSDS |
Product | Catalog No./ CAS No. | Quantity | Price | |
---|---|---|---|---|
687898 | 1X10MG | Please log in. | ||
2,3,3-D3-Acrylamide solution | 689557 | 1X1ML | Please log in. | |
2,3,3-D3-Acrylamide solution | 692397 | 1X5ML | Please log in. | |
675336 | 1X250MG | Please log in. | ||
Acrylamide solution | 689556 | 1X5ML | Please log in. |
Safety Data Sheet | according to Regulation (EC) No 1907/2006 (REACH) Classifications according to Regulation (EC) No 1272/2008. Printdate 15.01.2025 |
IDENTIFICATION OF THE SUBSTANCE/MIXTURE AND OF THE COMPANY/UNDERTAKING | |
Product name: | Acrylamide |
Catalog No.: | 675336 |
Relevant identified uses of the substance or mixture | Identified: Laboratory chemical uses: R&D |
Uses advised against: | HPC Standards GmbH Am Wieseneck 7 04451 Cunnersdorf Deutschland Tel. +49 34291 3372-36 Fax. +49 34291 3372-39 contact@hpc-standards.com |
Emergency telephone number | HPC Standards Tel. +49 34291 3372-36 This number is only available during office hours. |
HAZARDS IDENTIFICATION | 2.1 Classification of the substance or mixture Classification according to Regulation (EC) No 1272/2008 Carcinogenicity (Category 1B), H350 Germ cell mutagenicity (Category 1B), H340 Reproductive toxicity (Category 2), H361f Acute toxicity, Oral (Category 3), H301 Specific target organ toxicity - repeated exposure (Category 1), H372 Acute toxicity, Inhalation (Category 4), H332 Acute toxicity, Dermal (Category 4), H312 Eye irritation (Category 2), H319 Skin irritation (Category 2), H315 Skin sensitisation (Category 1), H317 Classification according to EU Directives 67/548/EEC or 1999/45/EC T Toxic R25, R48/23/24/25 R45 R46 R62 Xn Harmful R20/21 Xi Irritant R36/38 R43 |
Label elements | |
Pictogram | GHS06 skull skull GHS08 silhouete silhouete |
Signal word Danger Hazard statement(s) H301 Toxic if swallowed. H312 + H332 Harmful in contact with skin or if inhaled H315 Causes skin irritation. H317 May cause an allergic skin reaction. H319 Causes serious eye irritation. H340 May cause genetic defects. H350 May cause cancer. H361f Suspected of damaging fertility. H372 Causes damage to organs through prolonged or repeated exposure. Precautionary statement(s) P201 Obtain special instructions before use. P280 Wear protective gloves/ protective clothing. P301 + P310 IF SWALLOWED: Immediately call a POISON CENTER or doctor/ physician. P305 + P351 + P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P308 + P313 IF exposed or concerned: Get medical advice/ attention. Supplemental Hazard Statements none Restricted to professional users. 2.3 Other hazards - none | |
COMPOSITION/INFORMATION ON INGREDIENTS | 3.1 Substances Synonyms : Acrylic acid amide 2-Propenamide Formula : C3H5NO Molecular Weight : 71,08 g/mol CAS-No. : 79-06-1 EC-No. : 201-173-7 Index-No. : 616-003-00-0 Registration number : 01-2119463260-48-XXXX Hazardous ingredients according to Regulation (EC) No 1272/2008 Component Classification Concentration Acrylamide Included in the Candidate List of Substances of Very High Concern (SVHC) according to Regulation (EC) No. 1907/2006 (REACH) CAS-No. EC-No. Index-No. Registration number 79-06-1 201-173-7 616-003-00-0 01-2119463260-48-XXXX Carc. 1B; Muta. 1B; Repr. 2; Acute Tox. 3; STOT RE 1; Acute Tox. 4; Eye Irrit. 2; Skin Irrit. 2; Skin Sens. 1; H372, H319, H315, H301, H312, H317, H332, H340, H350, H361f <= 100 % Hazardous ingredients according to Directive 1999/45/EC Component Classification Concentration Acrylamide Included in the Candidate List of Substances of Very High Concern (SVHC) according to Regulation (EC) No. 1907/2006 (REACH) CAS-No. EC-No. Index-No. Registration number 79-06-1 201-173-7 616-003-00-0 01-2119463260-48-XXXX T, Carc.Cat.2, Mut.Cat.2, Repr.Cat.3, R45 - R46 - R20/21 - R25 - R36/38 - R43 - R48/23/24/25 - R62 <= 100 % |
Formula | C3H5NO |
Molecular Weight (g/mol) | 71.08 |
CAS-No. | 79-06-1 |
FIRST AID MEASURES | 4.1 Description of first aid measures General advice Consult a physician. Show this safety data sheet to the doctor in attendance. If inhaled If breathed in, move person into fresh air. If not breathing, give artificial respiration. Consult a physician. In case of skin contact Wash off with soap and plenty of water. Take victim immediately to hospital. Consult a physician. In case of eye contact Rinse thoroughly with plenty of water for at least 15 minutes and consult a physician. If swallowed Never give anything by mouth to an unconscious person. Rinse mouth with water. Consult a physician. 4.2 Most important symptoms and effects, both acute and delayed The most important known symptoms and effects are described in the labelling (see section 2.2) and/or in section 11 4.3 Indication of any immediate medical attention and special treatment needed no data available |
FIRE-FIGHTING MEASURES | 5.1 Extinguishing media Suitable extinguishing media Use water spray, alcohol-resistant foam, dry chemical or carbon dioxide. 5.2 Special hazards arising from the substance or mixture Carbon oxides, nitrogen oxides (NOx) 5.3 Advice for firefighters Wear self contained breathing apparatus for fire fighting if necessary. 5.4 Further information no data available |
ACCIDENTAL RELEASE MEASURES | 6.1 Personal precautions, protective equipment and emergency procedures Wear respiratory protection. Avoid dust formation. Avoid breathing vapours, mist or gas. Ensure adequate ventilation. Evacuate personnel to safe areas. Avoid breathing dust. For personal protection see section 8. 6.2 Environmental precautions Prevent further leakage or spillage if safe to do so. Do not let product enter drains. Discharge into the environment must be avoided. 6.3 Methods and materials for containment and cleaning up Pick up and arrange disposal without creating dust. Sweep up and shovel. Keep in suitable, closed containers for disposal. 6.4 Reference to other sections For disposal see section 13. |
HANDLING AND STORAGE | 7.1 Precautions for safe handling Avoid contact with skin and eyes. Avoid formation of dust and aerosols.Avoid exposure - obtain special instructions before use. Provide appropriate exhaust ventilation at places where dust is formed. For precautions see section 2.2. 7.2 Conditions for safe storage, including any incompatibilities Store in cool place. Keep container tightly closed in a dry and well-ventilated place. Light sensitive. Store under inert gas. 7.3 Specific end use(s) Apart from the uses mentioned in section 1.2 no other specific uses are stipulated |
EXPOSURE CONTROLS/PERSONAL PROTECTION | 8.1 Control parameters Components with workplace control parameters 8.2 Exposure controls Appropriate engineering controls Avoid contact with skin, eyes and clothing. Wash hands before breaks and immediately after handling the product. Personal protective equipment Eye/face protection Face shield and safety glasses Use equipment for eye protection tested and approved under appropriate government standards such as NIOSH (US) or EN 166(EU). Skin protection Handle with gloves. Gloves must be inspected prior to use. Use proper glove removal technique (without touching glove's outer surface) to avoid skin contact with this product. Dispose of contaminated gloves after use in accordance with applicable laws and good laboratory practices. Wash and dry hands. Body Protection Complete suit protecting against chemicals, The type of protective equipment must be selected according to the concentration and amount of the dangerous substance at the specific workplace. Respiratory protection Where risk assessment shows air-purifying respirators are appropriate use a full-face particle respirator type N100 (US) or type P3 (EN 143) respirator cartridges as a backup to engineering controls. If the respirator is the sole means of protection, use a full-face supplied air respirator. Use respirators and components tested and approved under appropriate government standards such as NIOSH (US) or CEN (EU). Control of environmental exposure Prevent further leakage or spillage if safe to do so. Do not let product enter drains. Discharge into the environment must be avoided. |
PHYSICAL AND CHEMICAL PROPERTIES | 9.1 Information on basic physical and chemical properties a) Appearance Form: solid b) Odour no data available c) Odour Threshold no data available d) pH 5,2 - 6 at 500 g/l e) Melting point/freezing point Melting point/range: 82 - 86 °C - lit. f) Initial boiling point and boiling range 125 °C at 33 hPa - lit. g) Flash point 138 °C - closed cup h) Evapouration rate no data available i) Flammability (solid, gas) no data available j) Upper/lower flammability or explosive limits no data available k) Vapour pressure 2,1 hPa at 84,50 °C 0,04 hPa at 40 °C 0,0900 hPa at 25 °C l) Vapour density 2,45 - (Air = 1.0) m) Relative density no data available n) Water solubility 200 g/l at 20 °C o) Partition coefficient: noctanol/ water log Pow: -0,67 p) Auto-ignition temperature no data available q) Decomposition temperature no data available r) Viscosity no data available s) Explosive properties no data available t) Oxidizing properties no data available 9.2 Other safety information Relative vapour density 2,45 - (Air = 1.0) |
STABILITY AND REACTIVITY | 10.1 Reactivity no data available 10.2 Chemical stability Stable under recommended storage conditions. 10.3 Possibility of hazardous reactions no data available 10.4 Conditions to avoid no data available 10.5 Incompatible materials Acids, Oxidizing agents, Iron and iron salts., Copper, Brass, Free radical initiators 10.6 Hazardous decomposition products Other decomposition products - no data available In the event of fire: see section 5 |
TOXICOLOGICAL INFORMATION | 11.1 Information on toxicological effects Acute toxicity LD50 Oral - rat - 177 mg/kg LC50 Inhalation - rat - 4 h - > 1.500 mg/m3 LD50 Dermal - rabbit - 1.141 mg/kg (OECD Test Guideline 402) Skin corrosion/irritation Skin - rabbit Result: No skin irritation (OECD Test Guideline 404) Remarks: Classified according to Regulation (EU) 1272/2008, Annex VI (Table 3.1/3.2) Serious eye damage/eye irritation Eyes - rabbit Result: Irritating to eyes. (OECD Test Guideline 405) Respiratory or skin sensitisation Maximisation Test - guinea pig May cause allergic skin reaction. (OECD Test Guideline 406) Germ cell mutagenicity May alter genetic material. In vivo tests showed mutagenic effects Carcinogenicity This product is or contains a component that has been reported to be probably carcinogenic based on its IARC, OSHA, ACGIH, NTP, or EPA classification. Possible human carcinogen IARC: 2A - Group 2A: Probably carcinogenic to humans (Acrylamide) Reproductive toxicity Animal testing did not show any effects on foetal development. May cause reproductive disorders. Suspected human reproductive toxicant Specific target organ toxicity - single exposure no data available Specific target organ toxicity - repeated exposure Oral - Causes damage to organs through prolonged or repeated exposure. - Peripheral nervous System Aspiration hazard no data available Additional Information RTECS: AS3325000 Liver - Irregularities - Based on Human Evidence |
ECOLOGICAL INFORMATION | 12.1 Toxicity Toxicity to fish LC50 - Pimephales promelas (fathead minnow) - 90 mg/l - 96 h NOEC - Cyprinus carpio (Carp) - 5 mg/l - 28 d Toxicity to daphnia and other aquatic invertebrates mortality NOEC - Daphnia magna (Water flea) - 60 mg/l - 48 h EC50 - Daphnia magna (Water flea) - 160 mg/l - 48 h 12.2 Persistence and degradability Biodegradability Result: 100 % - Readily biodegradable. (OECD Test Guideline 301D) 12.3 Bioaccumulative potential Bioaccumulation Oncorhynchus mykiss (rainbow trout) - 72 h - 710 μg/l Bioconcentration factor (BCF): 1,65 12.4 Mobility in soil no data available 12.5 Results of PBT and vPvB assessment PBT/vPvB assessment not available as chemical safety assessment not required/not conducted 12.6 Other adverse effects Harmful to aquatic life. no data available |
DISPOSAL CONSIDERATIONS | 13.1 Waste treatment methods Product Offer surplus and non-recyclable solutions to a licensed disposal company. Dissolve or mix the material with a combustible solvent and burn in a chemical incinerator equipped with an afterburner and scrubber. Contaminated packaging Dispose of as unused product. |
TRANSPORT INFORMATION | 14.1 UN number ADR/RID: 2074 IMDG: 2074 IATA: 2074 14.2 UN proper shipping name ADR/RID: ACRYLAMIDE, SOLID IMDG: ACRYLAMIDE, SOLID IATA: Acrylamide, solid 14.3 Transport hazard class(es) ADR/RID: 6.1 IMDG: 6.1 IATA: 6.1 14.4 Packaging group ADR/RID: III IMDG: III IATA: III 14.5 Environmental hazards ADR/RID: no IMDG Marine pollutant: no IATA: no 14.6 Special precautions for user no data available |
REGULATORY INFORMATION | This safety datasheet complies with the requirements of Regulation (EC) No. 1907/2006. 15.1 Safety, health and environmental regulations/legislation specific for the substance or mixture Authorisations and/or restrictions on use Acrylamide CAS-No.: 79-06-1 Candidate List of Substances of Very High Concern for Authorisation Carcinogenic (article 57a) ED/68/2009 Acrylamide CAS-No.: 79-06-1 Candidate List of Substances of Very High Concern for Authorisation Carcinogenic (article 57a) ED/68/2009 15.2 Chemical Safety Assessment For this product a chemical safety assessment was not carried out |
OTHER INFORMATION | The above information is believed to be correct but does not purport to be all inclusive and shall be used only as a guide. The information in this document is based on the present state of our knowledge and is applicable to the product with regard to appropriate safety precautions. It does not represent any guarantee of the properties of the product. For lab use only! |